*A hold will be placed on your card until your eligibility is determined. If you are not eligible for this test, the hold will be removed. No deductibles, co-pays, or surprise bills.
HSA/FSA Eligible.
Get tested for 44 key uropathogens, including ones that traditional urine culture cannot detect. With the BIOTIA-ID Urine Test, you can collect your urine sample in the privacy of your own home, receive comprehensive laboratory testing, and connect with a telehealth provider to review your results and put an end to your UTI symptoms.
After creating an account on the Biotia Portal, you will need to complete your patient intake and eligibility form. Our partner telehealth provider will confirm your eligibility and place the order for your test with our laboratory. In some circumstances, your provider may contact you ahead of receiving your test results depending on your medical history and current symptoms.
Clinova.Solutions charges a $10 fee to cover the Eligibility Review & Provider Text Message Support service included in your order. This fee is a requirement to use the BIOTIA-ID Urine Test and is automatically added to your cart. Telehealth visits are charged separately through Clinova.Solutions at $25 per visit.
Shipping will be charged at a flat rate of $48. This fee covers express delivery of the test kit to your address as well as overnight shipping back to the Biotia Laboratory.
Each test kit includes:
"Conventional tests failed to detect the true cause of my recurring UTI. BIOTIA-ID provided the clarity my doctor needed to treat it effectively. The BIOTIA-ID Urine Test really truly helped me immensely and I am ever grateful.
I'd had symptoms for 11 months before it!"
– Liora, New York
Urine culture is a technique that was invented in the 1800's and it is still considered the diagnostic gold-standard. However, not all bacteria and fungi that cause UTIs are able to grow in urine culture and many grow too slowly for results to be reported accurately. This test uses cutting-edge next-generation sequencing and machine learning to diagnose recurrent, complicated, and culture-negative urinary tract infections. Our test is able to look at all of the pathogen DNA in your urine to determine what is causing your infection and what treatment will work best.
Our founders started developing this technology at Cornell Tech years ago. After launching in 2015, we clinically validated this test in a CLIA-certified diagnostic laboratory using real patient specimens. We continue to participate in strict regulatory oversight for laboratory-developed tests across all 50 U.S. states. We have demonstrated a sensitivity of 97% and specificity of 99% for 44 known UTI pathogens and can detect 14 resistance marker genes for 6 different antibiotic resistance classes (regulatory approval pending). This helps your provider accurately identify the pathogen(s) causing your UTI and choose the treatment that will work.
We have worked with our telehealth providers to ensure you are getting the appropriate care. Rather than waiting for an appointment, a provider will determine if you are eligible for this test same-day. Following confirmation of eligibility, you will receive our easy-to-use, at-home test kit. After collecting your urine sample in the privacy of your home, you simply send your sample to the Biotia Laboratory using the prepaid, overnight shipping label included in the kit. Once you and your provider receive your test results, you will have the opportunity to schedule a follow-up visit to discuss treatment options and next steps.
A urinary tract infection (UTI) is an infection in any part of the urinary system. The urinary system includes the kidneys, ureters, bladder and urethra. Most infections involve the lower urinary tract — the bladder and the urethra.
UTIs don't always cause symptoms. When they do, they may include:
A large number of pathogens can cause urinary tract infections. These include different kinds of bacteria and fungi.
Some people are at higher risk for UTIs, such as people with female anatomy. Additionally, certain behaviors and activities can increase a person’s risk of getting a UTI.
These include:
Risk factors specific to people with female anatomy include:
Most UTIs are diagnosed through urine culture, and in some instances, through a technique called polymerase-chain reaction (PCR). Both of these types of tests have limitations – oftentimes known UTI-causing pathogens are missed. Our test overcomes this limitation by looking at all of the pathogen DNA in your urine sample through next-generation sequencing and machine learning.
Additionally, rather than simply generating a report for your use, we provide follow-up care with licensed clinicians trained in UTI management. Our team can handle the most challenging of cases – ensuring that you are receiving appropriate and exceptional care to treat your UTI symptoms.
You will receive your test kit within 1-2 days following eligibility confirmation by our partner telehealth provider. Please note that orders placed on Fridays may not be shipped out until the following Monday.
Your test kit includes a prepaid return label that ships your sample overnight directly to the Biotia Laboratory. To avoid weekend delays, we recommend that patients ship their samples Monday through Thursday. Holidays may impact return shipping. Check our website for notices of holiday closure.
Patients should ship their sample on the same day it is collected. Due to New York State regulations, samples that arrive more than 48 hours after collection cannot be accepted.
Our current days of operation are Monday-Friday. On average, results are reported within 3 business days following receipt of your sample by the Biotia Laboratory. Holidays may delay results.
You will receive notifications when your sample is received by our laboratory and when your results are ready for review.
Your results will indicate whether any of the 44 pathogens tested with BIOTIA-ID Urine were detected in your sample. If a pathogen is present and carries antibiotic resistance genes, you will receive a report that includes this information. Your clinician will review the findings and determine the most appropriate course of treatment based on the specific pathogens and any resistance genes identified.
Yes, you can discuss your test results with your own provider. We provide both our patients and our telehealth partner with a report containing your test results. You can access this report through the Biotia Patient Portal, which will allow you to download a PDF copy that you may bring to your own provider.
This test is the first-of-its-kind to receive approval as a laboratory-developed test across all 50 U.S. states. This means our test has met strict performance requirements that many wellness brands who purport to successfully diagnose you have not.
Biotia does not currently accept any insurance for the at-home collection of this test. The BIOTIA-ID Urine Test uses the latest technology in diagnostics and is the first-of-its-kind to be used on urine samples. Biotia is working with insurance companies to obtain coverage for this test.
This test is HSA/FSA Eligible.
No, the cost of prescription treatment is not included in the price of the BIOTIA-ID Urine Test. Should your provider determine you need a prescription to treat your UTI, they will send a prescription to your preferred pharmacy. You will be responsible for any costs incurred in obtaining the prescription.
The BIOTIA-ID Urine Test, including the telehealth services provided, is currently available for United States residents only. If you are an international patient, please reach out to customersupport@biotia.io to see how we might be able to help.
Currently, at-home collection for the BIOTIA-ID Urine Test is only approved for patients age 18 years or older. Patients who are under the age of 18 are unable to place an order for this test and will be unable to create a Biotia Patient Account.
Click the links to find PDF copies of the patient form and the collection instructions for at-home collection.
The BIOTIA-ID Urine NGS Assay has been approved by New York State Department of Health’s Clinical Laboratory Evaluation Program as an in vitro diagnostic laboratory developed test (LDT). This assay was developed and its performance characteristics determined by Biotia. The assay has not been cleared or approved by the FDA, nor is it required to be. The Biotia Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) and is accredited to perform high-complexity clinical laboratory testing.
